je.st
news
Merck, Baupost join $55M investment in early-stage biotech, RaNA
2015-07-24 18:09:58| Biotech - Topix.net
After selling his company Idenix Pharmaceuticals to Merck & Co. for $3.9 billion last August, Ronald Renaud has received support again from the New Jersey drug giant, this time in financing for his new company.
Tags: join
investment
biotech
merck
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||